EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 29 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-12-16: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2019-12-16: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2019-11-25: Reporting owner Cole G Bradley; Form 3/A; Security Stock Option (right to buy); Transaction Holding.
- 2019-11-25: Reporting owner Cole G Bradley; Form 3/A; Security Stock Option (right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-12-16 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,163 102,837 owned after | $13.96 exercise price | 2019-12-18 | |
| 2019-12-16 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,277 66,723 owned after | $23.38 exercise price | 2019-12-18 | |
| 2019-11-25 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $35.28 exercise price | 2019-11-25 | ||
| 2019-11-25 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $35.91 exercise price | 2019-11-25 | ||
| 2019-11-25 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $43.30 exercise price | 2019-11-25 | ||
| 2019-11-25 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $94.76 exercise price | 2019-11-25 | ||
| 2019-11-21 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $35.28 exercise price | 2019-11-21 | ||
| 2019-11-21 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $35.91 exercise price | 2019-11-21 | ||
| 2019-11-21 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $43.40 exercise price | 2019-11-21 | ||
| 2019-11-21 holding as of filing | Cole G Bradley Officer (General Manager - Diagnostics) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $94.76 exercise price | 2019-11-21 | ||
| 2019-11-21 holding as of filing | Hoof Torsten Officer (General Manager, International) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $41.53 exercise price | 2019-11-21 | ||
| 2019-11-21 holding as of filing | Hoof Torsten Officer (General Manager, International) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $43.40 exercise price | 2019-11-21 | ||
| 2019-11-21 holding as of filing | Hoof Torsten Officer (General Manager, International) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $94.76 exercise price | 2019-11-21 | ||
| 2019-07-31 | WYZGA MICHAEL S Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 10,108 owned after | $26.98 exercise price | 2019-08-02 | |
| 2019-07-31 | LEVANGIE DANIEL J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,168 0 owned after | $3.43 exercise price | 2019-08-02 | |
| 2019-07-31 | LEVANGIE DANIEL J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,667 0 owned after | $3.43 exercise price | 2019-08-02 | |
| 2019-07-31 | LEVANGIE DANIEL J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,772 0 owned after | $8.52 exercise price | 2019-08-02 | |
| 2019-04-29 holding as of filing | Hooker Ana Officer (SVP, Operations) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $23.38 exercise price | 2019-04-29 | ||
| 2019-04-29 holding as of filing | Hooker Ana Officer (SVP, Operations) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.03 exercise price | 2019-04-29 | ||
| 2019-04-29 holding as of filing | Hooker Ana Officer (SVP, Operations) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $21.68 exercise price | 2019-04-29 | ||
| 2019-04-29 holding as of filing | Hooker Ana Officer (SVP, Operations) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $44.37 exercise price | 2019-04-29 | ||
| 2019-04-29 holding as of filing | Hooker Ana Officer (SVP, Operations) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $92.62 exercise price | 2019-04-29 | ||
| 2019-02-26 | Stenhouse Mark Officer (President, Cologuard) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,786 10,786 owned after | $92.62 exercise price | 2019-02-28 | |
| 2019-02-26 | Johnson Scott C. Officer (SVP - Research and Development) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,741 6,741 owned after | $92.62 exercise price | 2019-02-28 | |
| 2019-02-26 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,361 11,361 owned after | $92.62 exercise price | 2019-02-28 | |
| 2019-02-26 | COWARD D SCOTT Officer (Chief Administrative Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,786 10,786 owned after | $92.62 exercise price | 2019-02-28 | |
| 2019-02-26 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,110 34,110 owned after | $92.62 exercise price | 2019-02-28 | |
| 2019-01-11 holding as of filing | Johnson Scott C. Officer (SVP - Research and Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $44.37 exercise price | 2019-01-11 | ||
| 2019-01-11 holding as of filing | Johnson Scott C. Officer (SVP - Research and Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $44.37 exercise price | 2019-01-11 |